跳至主要内容
临床试验/NCT07100652
NCT07100652尚未招募不适用

Comparing Different Oxygen Thresholds for Surfactant Administration During Nasal IPPV in Very Preterm Neonates With Respiratory Distress Syndrome: A Superiority RCT

Jiulongpo No.1 People's Hospital1 个研究点 分布在 1 个国家目标入组 384 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
384
试验地点
1
主要终点
Non-invasive respiratory support failure, defined by the need for IMV within 72 after birth

研究概览

简要总结

This multicenter randomized controlled trial investigates whether initiating pulmonary surfactant (PS) at a lower oxygen threshold (FiO₂ >0.25) during nasal intermittent positive pressure ventilation (NIPPV) for very preterm infants with respiratory distress syndrome (RDS) reduces noninvasive ventilation failure rates (primary outcome: intubation requirement), compared to the standard threshold (FiO₂ >0.3). By establishing the clinical superiority of early PS administration, this study aims to refine evidence-based guidelines for RDS management in preterm neonates.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
— 至 3 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • (1) Gestational Age: 26 weeks +0 day to 31 weeks+6days at birth (inclusive). (2) Clinical Diagnosis of NRDS: Symptoms: Tachypnea, grunting, and/or progressive respiratory distress. Imaging Findings: Chest X-ray showing at least one of: Ground-glass opacity, Air bronchograms, Diffuse "white lung" pattern, Lung Ultrasound (recommended).
  • (3) Admission to NICU within 3 hours of birth. Requirement for non-invasive nasal intermittent positive pressure ventilation (NIPPV) at enrollment.
  • (4) Signed informed consent obtained from parent(s) or legal guardian(s).

排除标准

  • Invasive mechanical ventilation during delivery or transport to NICU.
  • Structural upper airway abnormalities precluding non-invasive ventilation.
  • Confirmed diagnosis of major congenital malformations
  • Endotracheal intubation for indications unrelated to NRDS (e.g., surgery, sepsis management)
  • Initiation of non-invasive ventilation >3 hours post-birth.
  • Voluntary discharge or treatment withdrawal within 72 hours post-enrollment.
  • Parental/guardian refusal to Sign informed consent or Authorize surfactant administration
  • Incomplete clinical records or missing key outcome variables

结局指标

主要结局

Non-invasive respiratory support failure, defined by the need for IMV within 72 after birth

时间窗: 72 hours after birth

次要结局

  • The requirement for repeated pulmonary surfactant administration, including the total number of doses utilized(7 days after birth)
  • BPD, defined according to the NICHD definition(3 months after birth)
  • IVH > 2nd grade(3 mionths after birth)
  • total hospitalization cost(6 months after birth)
  • retinopathy of prematurity (ROP) > 2nd stage(3 months after birth)
  • weekly weight gain (in grams/d) for the first 4 weeks of life or until NICU discharge, whichever comes first.(3 months after birth)
  • Duration of non-invasive respiratory support(3 months after birth)
  • airleaks occurred after the extubation(3 months after birth)
  • necrotizing enterocolitis (NEC) ≥ 2nd stage(3 months after birth)
  • nasal skin injury(3 months after birth)
  • ventilator-free days(3 months after birth)
  • hemodynamically significant patent ductus arteriosus (PDA)(3 months after birth)
  • in-hospital mortality(6 months after birth)

研究者

发起方
Jiulongpo No.1 People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xingwang Zhu

Jiangxi Maternal and Child Health Hospital, Jiangxi, 337000, China

Jiulongpo No.1 People's Hospital

研究点 (1)

Loading locations...

相似试验